On 30 October 2025, Novo Nordisk announced the submission of an unsolicited proposal to acquire Metsera, Inc. (Metsera)1.

Novo Nordisk and Pfizer have revised their bids for Metsera, the obesity drug developer said on Tuesday. Novo's revised offer ...

The clash reflects the shifting landscape for weight loss and diabetes drugs, with Novo Nordisk trailing Eli Lilly as ...

Obesity drugmaker Metsera Inc. has gotten higher offers from both Novo Nordisk A/S and Pfizer Inc. in an ongoing battle for the startup.

Pfizer and Novo Nordisk have both offered to sweeten their bids for the US obesity biotech Metsera, in the latest development ...

Pfizer et Novo Nordisk se livrent une guerre de milliards pour se positionner sur le marché florissant des médicaments ...

Pfizer reported a drop in third-quarter profits Tuesday as lower sales of Covid-19 products more than offset gains in other ...

Gold Spot US Dollar, Pfizer Inc, US Dollar Index Futures, S&P 500 Futures. Read 's Market Analysis on Investing.com ...

Pfizer has increased its annual profit forecast and reported higher-than-expected profits for the third quarter amid a legal ...